A comprehensive systematic review of the types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class
Expert Review of Clinical Pharmacology · 2025
DOI: 10.1080/17512433.2025.2585449 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Expert Review of Clinical Pharmacology, 2025. Verfasst von Faisal Madanat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, Scotland, UK. Hauptthemen laut MEDLINE: Deprescriptions, Inappropriate Prescribing. Die Arbeit nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
INTRODUCTION: Polypharmacy and potentially inappropriate medications (PIMs) contribute to adverse outcomes. Deprescribing, the supervised withdrawal of PIMs, is a key strategy to reduce these risks. Identifying the most targeted PIMs and commonly used tools for deprescribing remains essential. The aim of this systematic review was to identify the medication classes targeted by deprescribing tools, stratified by tool type and frequency and to evaluate the availability of medication-specific tools. METHODS: A systematic search of Embase, PubMed, Scopus, and Medline (2010-2023) identified observational and experimental studies using polypharmacy and deprescribing terms. The Newcastle-Ottawa Scale (NOS) and the revised Cochrane risk-of-bias tool (RoB 2) were used for quality assessment. Medication classes and tools/interventions were summarized in the TOTALLY TARGETED List. RESULTS: Eighty-two studies identified 44 deprescribing tools targeting 77 medication classes. The top PIMs were benzodiazepines, antipsychotics, alpha-receptor blockers, proton pump inhibitors, and Z-hypnotics. The most used tools were Screening Tool of Older People's Prescriptions (STOPP) Frail, American Geriatric Society (AGS) Beers Criteria, STOPP Criteria, and STOPPFall. Several medication-specific tools (e.g. PIMs in cognitively impaired patients) were also identified. CONCLUSION: This review identified the most targeted medication classes and deprescribing tools, emphasizing the need for medication-specific and patient-centered approaches to improve safety and outcomes. PROTOCOL REGISTRATION: https://www.crd.york.ac.uk/prospero//CRD42023442654.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, Scotland, UK.
- Faculty of Pharmacy, Mutah University, Al-Karak, Jordan.
- Department of Pharmacy Practice, College of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
- Department of Pharmacology and Toxicology, College of Pharmacy, Hawler Medical University, Erbil, Iraq.
- Department of Clinical Pharmacy, College of Pharmacy, Al-Kitab University, Kirkuk, Iraq.
- School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
Zitieren
APA
Madanat, F., Noorsaeed, S., Alkhlaifat, R., Mueller, T., & Kurdi, A. (2025). A comprehensive systematic review of the types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class. Expert Review of Clinical Pharmacology. https://doi.org/10.1080/17512433.2025.2585449
Vancouver
Madanat F, Noorsaeed S, Alkhlaifat R, Mueller T, Kurdi A. A comprehensive systematic review of the types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class. Expert Review of Clinical Pharmacology. 2025. doi:10.1080/17512433.2025.2585449
BibTeX
@article{Madanat2025,
author = {Madanat, Faisal and Noorsaeed, Solafa and Alkhlaifat, Rahaf and Mueller, Tanja and Kurdi, Amanj},
title = {A comprehensive systematic review of the types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class},
journal = {Expert Review of Clinical Pharmacology},
year = {2025},
doi = {10.1080/17512433.2025.2585449}
}
EUVIMED